Related Experiment Video
Updated: Oct 17, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome.
Abstract:
Clinical and experimental observations suggest that aggregation of polymorphonuclear granulocytes (PMN) in response to activated complement (C) might contribute to the genesis of the adult respiratory distress syndrome (ARDS), aggregating PMN causing pulmonary dysfunction by becoming lodged in the lung as leucoemboli. PMN-aggregating activity can be detected in C-activated plasma and reflects C5a levels. In 61 patients at risk for ARDS a strong and highly significant correlation was found between the presence of PMN-aggregating activity in the plasma and the development of ARDS; this correlation was also significant when patients with sepsis were excluded from analysis. In patients followed prospectively detection of elevated C5a seemed to be a useful predictor of ARDS. Since corticosteroids have been shown to inhibit PMN aggregation both in vitro and in vivo, the evidence for a role for PMN aggregation in the genesis of ARDS supports the use of corticosteroids in this disorder.
Insights
Polymorphonuclear granulocyte (PMN) aggregation, driven by complement activation (C5a), is linked to adult respiratory distress syndrome (ARDS) development. Elevated C5a levels may predict ARDS, supporting corticosteroid use.
Area of Science:
- Immunology
- Pulmonology
- Critical Care Medicine
Background:
- Polymorphonuclear granulocyte (PMN) aggregation, stimulated by activated complement (C), is implicated in adult respiratory distress syndrome (ARDS) pathogenesis.
- Aggregated PMNs can lodge in pulmonary vasculature, causing dysfunction and contributing to ARDS.
- PMN-aggregating activity in plasma correlates with complement fragment C5a levels.
Purpose of the Study:
- To investigate the correlation between PMN-aggregating activity and ARDS development in at-risk patients.
- To assess the predictive value of elevated C5a levels for ARDS onset.
- To evaluate the potential therapeutic implications of PMN aggregation findings.
Main Methods:
- Plasma samples from 61 patients at risk for ARDS were analyzed for PMN-aggregating activity.
- C5a levels were measured in plasma samples.
- Correlation analyses were performed between PMN-aggregating activity, C5a levels, and ARDS development, including subgroup analysis excluding sepsis patients.
Main Results:
- A strong, significant correlation was observed between plasma PMN-aggregating activity and ARDS development.
- This correlation remained significant even when patients with sepsis were excluded.
- Prospective monitoring indicated that elevated C5a levels were a useful predictor of ARDS.
Conclusions:
- PMN aggregation in response to complement activation plays a significant role in ARDS genesis.
- Elevated C5a levels serve as a potential early predictor for ARDS.
- The findings support the use of corticosteroids, known to inhibit PMN aggregation, in managing ARDS.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Complement System
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

